𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints

✍ Scribed by DJ Bloomfield; MD Krahn; AR Willan; IF Tannock


Book ID
119578807
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
164 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.